Home/Filings/4/0001104659-25-087487
4//SEC Filing

Shulman Joseph 4

Accession 0001104659-25-087487

CIK 0001649904other

Filed

Sep 3, 8:00 PM ET

Accepted

Sep 4, 4:30 PM ET

Size

13.4 KB

Accession

0001104659-25-087487

Insider Transaction Report

Form 4
Period: 2025-09-02
Shulman Joseph
Chief Technical Officer
Transactions
  • Exercise/Conversion

    Stock Options (Right to Buy)

    2025-09-022,09416,750 total
    Exercise: $27.35Exp: 2033-01-31Common Stock (2,094 underlying)
  • Exercise/Conversion

    Common Stock

    2025-09-02$27.35/sh+2,094$57,27110,603 total
  • Sale

    Common Stock

    2025-09-02$105.30/sh16,781$1,767,0068,509 total
  • Exercise/Conversion

    Stock Options (Right to Buy)

    2025-09-0214,68722,813 total
    Exercise: $30.66Exp: 2031-02-10Common Stock (14,687 underlying)
  • Exercise/Conversion

    Common Stock

    2025-09-02$30.66/sh+14,687$450,30325,290 total
Footnotes (4)
  • [F1]The sale reported in this Form 4 was effected pursuant to Rule 10b5-1 instruction adopted on August 8, 2024.
  • [F2]The price reported in Column 4 is a weighted average price. The securities were sold in multiple transactions at prices ranging from $105.00 to $105.82 per common stock. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  • [F3]The stock options were granted on February 1, 2023. The options vest and become exercisable in 16 substantially equal installments upon the Reporting Person's completion of each three full months of successive service to the Issuer following the grant date.
  • [F4]The stock options were granted on February 11, 2021. The options vest and become exercisable in 16 substantially equal installments upon the Reporting Person's completion of each three full months of successive service to the Issuer following the grant date.

Issuer

RHYTHM PHARMACEUTICALS, INC.

CIK 0001649904

Entity typeother

Related Parties

1
  • filerCIK 0001909855

Filing Metadata

Form type
4
Filed
Sep 3, 8:00 PM ET
Accepted
Sep 4, 4:30 PM ET
Size
13.4 KB